Live Analyst Rating Changes 17069 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Nasib Ahmed
UBS

Nasib Ahmed

UBS
Wall Street Analyst
★★★★☆
#387
on 13Foresight · ranked by our own returns
76%
Success Rate
+10.7%
Average Return
13 of 17 calls profitable · +0.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 76% of Nasib Ahmed's ratings turned a profit when each position was held for 1 year — averaging +10.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

29 Buy 22 Hold 2 Sell
Nasib's Stock Coverage 17 ratings · 2026-08-05
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
GB:PRU
Prudential
 Aug 04, 2026 BUY Strong Buy
+718.4% avg upside
23 analysts
$1515.00
39.38% Upside
 · ·
GB:STJ
St. James's Place
 Jul 30, 2026 BUY Buy
+439.2% avg upside
16 analysts
$1515.00
38.69% Upside
 · ·
NL:AGN
Aegon NV
 May 29, 2026 HOLD Buy
-15.6% avg upside
11 analysts
$7.05
14.41% Downside
 +16.0% ·
CH:SLHN
Swiss Life Holding AG
 May 20, 2026 SELL Hold
-13.1% avg upside
5 analysts
$850.00
10.80% Downside
 -10.9% ·
GB:MNG
M&G Plc
 May 05, 2026 HOLD Buy
-16.1% avg upside
14 analysts
$300.00
17.36% Downside
 +16.6% ·
GB:SDLF
Standard Life plc
 Apr 20, 2026 BUY Buy
-11.6% avg upside
13 analysts
$870.00
5.90% Downside
 +18.7% ·
CH:HBAN
Helvetia Holding AG
 Apr 09, 2026 BUY Hold
-22.5% avg upside
3 analysts
$225.00
4.63% Upside
 +4.3% ·
GB:LGEN
Legal & General
 Mar 20, 2026 HOLD Hold
+450.5% avg upside
17 analysts
$250.00
17.53% Downside
 +27.0% ·
GB:AV
Aviva plc
 Mar 11, 2026 BUY Buy
-5.3% avg upside
17 analysts
$750.00
7.81% Upside
 +10.9% ·
NL:ASRNL
ASR Nederland N.V
 Feb 24, 2026 HOLD Buy
-2.2% avg upside
9 analysts
$66.50
5.84% Downside
 +18.0% ·
GB:0Q99
ageas NV
 Jan 20, 2026 HOLD Buy
-19.0% avg upside
9 analysts
$61.00
17.08% Downside
 · ·
NL:NN
NN Group N.V.
 Aug 12, 2025 HOLD Buy
-18.7% avg upside
13 analysts
$66.30
18.45% Downside
 +40.1% ·
DE:MUV2
Munich Reinsurance
 Dec 07, 2023 HOLD Buy
-6.4% avg upside
17 analysts
 — +35.2% ·
DE:ALV
Allianz
 Dec 07, 2023 BUY Buy
-15.5% avg upside
23 analysts
 — +30.3% ·
AEG
Aegon
 Jan 12, 2023 BUY Buy
-51.1% avg upside
8 analysts
 — +11.2% ·
FR:CS
AXA SA
 Oct 11, 2021 HOLD Strong Buy
+1.9% avg upside
19 analysts
 — +0.5% ·
IT:G
Assicurazioni Generali S.p.A.
 Oct 11, 2021 HOLD Buy
-19.1% avg upside
16 analysts
 — -20.8% ·
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Nasib Ahmed — Frequently Asked Questions
How accurate are Nasib Ahmed's stock ratings?
Based on the calls 13Foresight could measure, about 76% of Nasib's ratings were profitable over a one-year hold, with an average return of +10.7% per rating, or +1.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Nasib ranked on 13Foresight?
Nasib Ahmed is currently ranked #387 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Nasib cover?
Nasib most recently has ratings on GB:PRU, GB:STJ, NL:AGN, CH:SLHN, GB:MNG, GB:SDLF, CH:HBAN, GB:LGEN, GB:AV, NL:ASRNL, GB:0Q99, NL:NN and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.